- Home
- SON vs ALKS Comparison
SON vs ALKS Comparison
Compare SON & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SON
- ALKS
- Stock Information
- Founded
- SON 1899
- ALKS 1987
- Country
- SON United States
- ALKS Ireland
- Employees
- SON N/A
- ALKS N/A
- Industry
- SON Containers/Packaging
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- SON Consumer Discretionary
- ALKS Health Care
- Exchange
- SON Nasdaq
- ALKS Nasdaq
- Market Cap
- SON 4.5B
- ALKS 4.8B
- IPO Year
- SON N/A
- ALKS 1991
- Fundamental
- Price
- SON $44.54
- ALKS $30.56
- Analyst Decision
- SON Strong Buy
- ALKS Buy
- Analyst Count
- SON 7
- ALKS 13
- Target Price
- SON $57.43
- ALKS $38.85
- AVG Volume (30 Days)
- SON 725.2K
- ALKS 1.6M
- Earning Date
- SON 07-30-2025
- ALKS 07-23-2025
- Dividend Yield
- SON 4.66%
- ALKS N/A
- EPS Growth
- SON N/A
- ALKS N/A
- EPS
- SON 1.54
- ALKS 2.09
- Revenue
- SON $5,705,957,000.00
- ALKS $1,513,770,000.00
- Revenue This Year
- SON $47.17
- ALKS N/A
- Revenue Next Year
- SON N/A
- ALKS $4.11
- P/E Ratio
- SON $55.51
- ALKS $14.52
- Revenue Growth
- SON 13.66
- ALKS N/A
- 52 Week Low
- SON $39.46
- ALKS $22.90
- 52 Week High
- SON $61.73
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- SON 46.02
- ALKS 54.70
- Support Level
- SON $44.89
- ALKS $29.70
- Resistance Level
- SON $46.83
- ALKS $31.76
- Average True Range (ATR)
- SON 0.82
- ALKS 0.73
- MACD
- SON -0.06
- ALKS -0.01
- Stochastic Oscillator
- SON 9.43
- ALKS 66.02
About SON Sonoco Products Company
Over its 100-year-plus history, Sonoco Products has steadily assembled a diverse portfolio of industrial and consumer packaging product offerings such as flexible and rigid plastics, reels and spools, pallets, and composite cans. The company serves a variety of consumer and industrial end markets throughout North America. Sonoco has raised its dividend each year for more than 40 years.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.